Investment archive

Investment feed — page 12

Back to latest investments

Eli Radiopharma announces Series A of almost €54M to advance cancer and neurological radiopharmaceuticals

Eli Radiopharma announces Series A of almost €54M to advance cancer and neurological radiopharmaceuticals

Issuer confirms completed Series A of almost €54M (ECB-converted estimate, not an exact disclosed sum). Huagai Capital leads with Bayland co-leading. Proceeds target preclinical validation, trials and IND filings; no approved therapy, commercial revenue or valuation disclosed. Date denotes China issuer announcement; US wire is Nov 11 ET.

The 81 Collection reaches $82M cumulative commitments at an additional Fund II close

The 81 Collection reaches $82M cumulative commitments at an additional Fund II close

GP-issued November 11, 2026 release and transaction counsel confirm an additional close taking The 81 Collection Fund II to $82M cumulative commitments. This is NOT $82M in new commitments solely at the November close; incremental tranche and final closing date are undisclosed. DNS Capital is a returning LP. Fund targets minority positions of about $8M–$10M in founder-owned services and manufacturers with $4M–$20M revenue and at least 40% growth. GP reports manager-wide AUM above $145M, separate from Fund II commitments.

XpertDox announces $20M Series A led by Savant Growth for AI medical coding

XpertDox announces $20M Series A led by Savant Growth for AI medical coding

Nov 11 issuer release verifies $20M Series A from Savant Growth with its investment partner Kennet Partners. Exact legal closing date and company valuation undisclosed. Product-performance percentages are vendor-reported, not audited.

Imprint announces $130M new financing at approximately $1.9B valuation led by Khosla Ventures

Imprint announces $130M new financing at approximately $1.9B valuation led by Khosla Ventures

Imprint announced $130M of new financing on November 11, 2026, led by Khosla Ventures with existing backers Hedosophia, Ribbit, Spice and Thrive plus new Positive Sum. The issuer did not assign a Series E label or specify the pre-/post-money valuation basis. Separate $1.5B incremental warehouse credit capacity and asset-backed securitization are not equity financing.

Torus secures $500M growth capital led by Magnetar for modular AI inference infrastructure

Torus secures $500M growth capital led by Magnetar for modular AI inference infrastructure

Torus announced $500M in growth capital on November 11, 2026 alongside its Foundry product launch. Magnetar led with ICONIQ, Origin Ventures, Ridgeline Partners and Trinity Capital participating. Company specifies neither equity/debt breakdown nor valuation or legal completion date; independent Data Center Dynamics called it Series C. Foundry 1–20 MW sites and 12–16-week timeline are company forecasts; 47,000 GPUs by end-2027 is a goal.

RedBlue Capital Fund II holds first close; amount undisclosed, targets at least $50M

RedBlue Capital Fund II holds first close; amount undisclosed, targets at least $50M

RedBlue Capital founder Olaf Sakkers told TechCrunch in an original November 11, 2026 interview that the firm's second venture vehicle had held its first close, while expecting a final fund of at least $50M. This is a FUNDRAISING GOAL, not the sum already closed. Initial close amount, LP names and commitments, final size and legal close date were not disclosed. RedBlue reports $50K–$100K typical early-stage checks in real-economy startups; those are manager-wide guidelines.

VectorY announces €74.5M mixed financing including €30M EIB convertible loan

VectorY announces €74.5M mixed financing including €30M EIB convertible loan

VectorY Therapeutics announced €74.5M of new financing on November 11, 2026. This is a MIXED package, not a €74.5M equity round: the European Investment Bank confirmed a €30M convertible loan and Invest-NL confirmed €7M equity. Other equity amounts, transaction close date and valuation are undisclosed. Funds support PIONEER-ALS Phase 1/2 and a Huntington's program.

Plurai announces $13M seed led by Team8 for AI-agent simulation

Plurai announces $13M seed led by Team8 for AI-agent simulation

Plurai issued a November 11, 2026 $13M seed-round announcement led by Team8, with U&I, Velocity, Mercer and angels participating. Alongside its public launch, the company offers sandboxed simulation of enterprise AI-agent workflows and a separate small-model post-training product. The round's valuation, exact legal closing date and independent performance validation are undisclosed.

Coreshell closes $30M Series B co-led by Ferroglobe and Access Industries

Coreshell closes $30M Series B co-led by Ferroglobe and Access Industries

Company-issued November 11, 2026 press release announces a $30M Series B closing, co-led by Ferroglobe and Access Industries. Participation includes ADS, Helios Ventures, Pegasus Tech Ventures, Mana Ventures and Entrada Ventures. The $50M DOE project selection is not equity, and the $24M March 2025 strategic round is separate. Precise legal close date and valuation were undisclosed.

Course Corrected VC Fund II reportedly reaches €80M final close

Course Corrected VC Fund II reportedly reaches €80M final close

EU-Startups reported Nov 11 that Course Corrected VC Fund II finalized €80M. GP's own newsroom still lists Feb 2025 first close but not the new final-close announcement. EIF's €34.6M and Saminvest commitments are historic 2025 LP capital, not new 2026 commitments. Legal close day and fee terms undisclosed.

sennder discloses €155M factoring, venture-debt and supply-chain finance facilities

sennder discloses €155M factoring, venture-debt and supply-chain finance facilities

sennder's Nov 11 disclosure describes €100M Coface non-recourse factoring, €40M EIB venture debt and €15M cflox/Deutsche Bank supply-chain finance, totaling €155M. Facilities are live, with cflox operating since August 2026. This is credit/working-capital capacity, NOT equity or a newly closed venture round.

Fractile raises $720M Series C at reported $7B valuation with UK sovereign backing

Fractile raises $720M Series C at reported $7B valuation with UK sovereign backing

November 11 original Reuters reporting says Fractile confirmed a $720M Series C at $7B valuation (pre/post basis unspecified), with Thrive Capital, Founders Fund, Lightspeed and Redpoint among leaders. UK government separately confirms its Sovereign AI and British Business Bank funding as part of a Series C above its GBP-denominated threshold, but their individual tickets are not public. First production chip not shipped, so 10x claims/2027 deployments remain forward-looking.